19.10.2023
Cardiovascular diseases get Acino employees to open their hearts
In line with Acino’s commitment to improving patients’ lives, we regularly organise health awareness initiatives with our employees, the ambassadors...
Acino
News
29.09.2023
Acino Recognizes World Heart Day 2023
Acino, recognizes the significance of cardiovascular health and is dedicated to advancing heart care through innovative solutions and patient education....
26.09.2023
Meet Eva Kopecna, Global Head Regulatory Affairs, Medical and Pharmacovigilance
Dedication and expertise are key qualities needed to deliver flexible solutions. We are fortunate to have a group of experts...
20.09.2023
Acino Significantly Expands Presence and Capabilities in Latin America Through Acquisition of M8 Pharmaceuticals
Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets....
14.09.2023
Acino releases company’s first ever Sustainability Report
Report reflects Acino’s commitment to Environmental, Social, and Governance sustainability including goal of reaching carbon neutrality by 2050. ZURICH, Switzerland,...
12.09.2023
Martin Valks, Head of Out-Licensing, on business opportunities for European markets
In today’s pharmaceutical market, with higher regulatory demands and greater attention to compliance and Quality Assurance, customers are increasingly demanding...
20.07.2023
John Norman and Acino on shaping the healthcare landscape of Africa
Read the full interview with John Norman in the Executive Forecast magazine and get a glimpse into the innovative strategies...
06.07.2023
AD Ports Logistics and Acino Sign a Global Pharma Freight Forwarding Agreement
Milestone Agreement Inaugurates New Partnership and Signals AD Ports Logistics’ Further Expansion into the Global Healthcare & Lifesciences Logistics Sector...
26.06.2023
Acino appoints Max Sorokin as CFO
We are pleased to announce that Max Sorokin, has been appointed as Acino’s Chief Financial Officer, effective immediately. Max is...